Comparison in metabolic control and treatment satisfaction with continuous subcutaneous insulin infusion and multiple daily injections in children at onset of type 1 diabetes mellitus
Not Applicable
Completed
- Conditions
- Type 1 diabetes mellitusNutritional, Metabolic, Endocrine
- Registration Number
- ISRCTN64351161
- Lead Sponsor
- County of Gävleborg (Sweden)
- Brief Summary
2008 results in: https://www.ncbi.nlm.nih.gov/pubmed/18721168 (added 16/05/2019)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 72
Inclusion Criteria
Children and adolescents (age 7 to 17 years) with newly diagnosed (within 3 weeks) type 1 diabetes mellitus.
Exclusion Criteria
Other relavent diseases.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <br> The following were measured at baseline, 1 month, 6, 12 and 24 months:<br> 1. Metabolic control (HbA1c)<br> 2. Treatment satisfaction (Qestionnaires Diabetes Treatment Satisfaction Questionnaire [DTSQ])<br> 3. Safety (Registration of hospitalization for ketoacidosis [defined as pH <7.3] and major hypoglycemic episodes and/or technical problems)<br>
- Secondary Outcome Measures
Name Time Method <br> The following were measured at baseline, 1 month, 6, 12 and 24 months:<br> 1. BMI<br> 2. Isulin requirment<br> 3. Adverse events<br> 4. C-petide<br> 5. insulin-like growth factor-1 (IGF-1)<br> 6. Binding proteins<br>